Belarus vs Singapore: New or unknown treatment history cases: Pulmonary, bacteriologically
Belarus
1,117
in 2023
Singapore
1,032
in 2023
Belarus rank
107th
Singapore rank
109th
New or unknown treatment history cases: Pulmonary, bacteriologically over time
- Belarus
- Singapore
How they compare
Belarus currently reports 1,117 against 1,032 in Singapore, a difference of 85.
That makes Belarus's figure about 1.1 times Singapore's.
The two have swapped places 2 times across 11 shared years of data; in 2013 it was Belarus ahead.
Belarus ranks 107th and Singapore ranks 109th of 197 countries.
Belarus has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Belarus | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,841 | 1,116 | 725 | Belarus |
| 2020s | 1,092 | 1,058 | 34.25 | Belarus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new or unknown treatment history cases: pulmonary, bacteriologically, Belarus or Singapore?
- Belarus, at 1,117 against 1,032 in Singapore as of 2023.
- What is the difference in new or unknown treatment history cases: pulmonary, bacteriologically between Belarus and Singapore?
- 85, with Belarus ahead.
- How many years of comparable data are there for Belarus and Singapore?
- 11 years are reported by both, from 2013 to 2023.
- How do Belarus and Singapore rank globally for new or unknown treatment history cases: pulmonary, bacteriologically?
- Belarus ranks 107th and Singapore ranks 109th of 197 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New or unknown treatment history cases: Pulmonary, bacteriologically confirmed. Statizoid refreshes it automatically from the source and publishes the full history for both places.